secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSMED Inc (INSM)
CIK:        0001104506
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001140361-24-028710
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insmed to host commercial webinar on June 4 to discuss market outlook for ARIKAYCE, brensocatib, treprostinil palmitil
--------------------------------------------------------------------------------

- Webinar at 8:00 a.m. ET on June 4, 2024, live via investor relations website.
- Focus on three programs: ARIKAYCE (amikacin liposome inhalation), brensocatib, and treprostinil palmitil inhalation powder.
- Slide presentation furnished as Exhibit 99.1 with title slide only; no specific financial data disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1104506/000114036124028710/0001140361-24-028710-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1104506/000114036124028710/ef20030527_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-028710

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer